Home > Publications database > Antibiotic–Polycationic Peptide Conjugation as an Effective Strategy to Overcome Daptomycin Resistance > print

001     300132
005     20250330015832.0
024 7 _ |a 10.1002/adtp.202400473
|2 doi
024 7 _ |a altmetric:175349301
|2 altmetric
037 _ _ |a DKFZ-2025-00629
082 _ _ |a 610
100 1 _ |a Rasheed, Sari
|b 0
245 _ _ |a Antibiotic–Polycationic Peptide Conjugation as an Effective Strategy to Overcome Daptomycin Resistance
260 _ _ |a Weinheim
|c 2025
|b Wiley-VCH Verlag
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1743061370_27949
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a NMR Spectroscopy Analysis Unit, German Cancer Research Center
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Umstätter, Florian
|b 1
700 1 _ |a Mühlberg, Eric
|b 2
700 1 _ |a Beijer, Barbro
|b 3
700 1 _ |a Hertlein, Tobias
|b 4
700 1 _ |a Klika, Karel
|0 P:(DE-He78)c53db83479d3d1265967405af71f69bb
|b 5
700 1 _ |a Kleist, Christian
|b 6
700 1 _ |a Werner, Julia
|b 7
700 1 _ |a Domhan, Cornelius
|b 8
700 1 _ |a Bingel, Mara
|b 9
700 1 _ |a Müller, Anna
|b 10
700 1 _ |a Rausch, Marvin
|b 11
700 1 _ |a Zimmermann, Stefan
|b 12
700 1 _ |a Ohlsen, Knut
|b 13
700 1 _ |a Haberkorn, Uwe
|b 14
700 1 _ |a Koch, Marcus
|b 15
700 1 _ |a Bischoff, Markus
|b 16
700 1 _ |a Schneider, Tanja
|b 17
700 1 _ |a Müller, Rolf
|b 18
700 1 _ |a Herrmann, Jennifer
|b 19
700 1 _ |a Mier, Walter
|b 20
700 1 _ |a Uhl, Philipp
|0 0000-0002-8616-5599
|b 21
773 _ _ |a 10.1002/adtp.202400473
|g p. 2400473
|0 PERI:(DE-600)2920320-X
|p nn
|t Advanced therapeutics
|v nn
|y 2025
|x 2366-3987
909 C O |o oai:inrepo02.dkfz.de:300132
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)c53db83479d3d1265967405af71f69bb
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-20
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-20
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-20
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-20
920 1 _ |0 I:(DE-He78)A390-20160331
|k A390
|l AG Wirkstoffforschung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A390-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21